Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Multicompartment Models: Overview
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Metabolism: Phase I Reactions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 14, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Changda Gong1, Jiaojiao Fang1, Guixia Liu1
1Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China.
ULCYP, a new deep learning model, accurately predicts cytochrome P450 (CYP) induction using limited data. This computational approach aids drug discovery by identifying potential drug-drug interactions and toxicity risks early on.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: